[Paralysing neutropenia].
Dolmazon
C
C
Service de médecine interne, hôpital de L'Antiquaille, Lyon.
Desmurs
H
H
Girard-Madoux
M H
MH
Coppere
B
B
Aymard
M
M
Ninet
J
J
D000208:Acute Disease; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009188:Myelitis, Transverse / Q000175:diagnosis* / Q000209:etiology; D009503:Neutropenia / Q000209:etiology*; D010243:Paralysis / Q000209:etiology*; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use; D011019:Pneumonia, Mycoplasma / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D013997:Time Factors
D000900:Anti-Bacterial Agents; D010406:Penicillins; D019818:Clavulanic Acid; D000658:Amoxicillin
Une neutropénie paralysante.